tiprankstipranks
Advertisement
Advertisement

GeneDx falls after Natera launches sequencing assay for rare diseases

Shares of GeneDx (WGS) are down $3.70 to $81.40 in premarket trading.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Read More on WGS:

Disclaimer & DisclosureReport an Issue

1